AION — Aion Therapeutic Cashflow Statement
0.000.00%
Last trade - 00:00- CA$8.23m
- CA$9.92m
Annual cashflow statement for Aion Therapeutic, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.93 | -0.673 | -8.27 | -3.82 | -0.257 |
| Depreciation | |||||
| Non-Cash Items | 3.54 | -0.064 | 5.78 | 1.01 | -0.609 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.07 | 0.074 | 0.225 | 1.4 | 0.807 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.32 | -0.552 | -2.13 | -1.35 | -0.041 |
| Capital Expenditures | -1.95 | -0.205 | -1.44 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.063 | -0.129 | 0.065 | 0 | 0.135 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.01 | -0.333 | -1.38 | 0 | 0.135 |
| Financing Cash Flow Items | -0.181 | 0 | 0.331 | -0.026 | 0.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.286 | -0.125 | 3 | 1.2 | 0.163 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.62 | -1.01 | -0.373 | -0.24 | 0 |